Movalis (meloxicam) tablets 15 mg. №20

Description

Movalis composition
active substance: 1 tablet contains meloxicam 15 mg;
Excipients: sodium citrate, lactose monohydrate, microcrystalline cellulose, povidone, colloidal anhydrous silica, crospovidone, magnesium stearate.

Dosage form
Tablets.

Indications
Movalis is prescribed if the patient suffers from rheumatoid arthritis, arthrosis, osteoarthritis, ankylosing spondylitis, osteoarthritis and degenerative joint lesions.

Contraindications

• exacerbation of peptic ulcers of the stomach or duodenum;
• severe form of renal or hepatic failure;
• there is a pronounced “aspirin” triad, which includes aspirin intolerance, nasal sinus polyps and bronchial asthma.

The injectable form of Movalis is not prescribed to persons receiving anticoagulant treatment: this can cause intramuscular hematomas.

Children
Contraindicated for children under 16 years

Application during pregnancy and lactation
Not assigned.

Method of application and dosage
The total daily amount of the drug should be used once.

• Exacerbation of osteoarthritis:
  7.5 mg / day (1 tablet of 7.5 mg or half a tablet of 15 mg). If necessary, the dose can be increased to 15 mg / day (1 tablet of 15 mg or 2 tablets of 7.5 mg).
• Rheumatoid arthritis, ankylosing spondylitis:
  15 mg / day (1 tablet of 15 mg or 2 tablets of 7.5 mg).
  According to the therapeutic effect, the dose can be reduced to 7.5 mg / day (1 tablet of 7.5 mg or half a tablet of 15 mg).

Do not exceed a dose of 15 mg / day.

Overdose
In case of an overdose, there is an increase or the occurrence of adverse reactions from the administration of the drug.

Side effects
The drug is capable of negatively affecting various systems of the human body.

• In case of disruption of the digestive tract, it is possible to develop nausea, vomiting, pain in the abdomen, flatulence, increased or decreased stool. Also, with oral administration of the drug, belching, esophagitis, ulcerative lesions of the gastrointestinal tract, micro and macro gastrointestinal bleeding, gastritis and colitis may occur.
• On the part of the hematopoietic organs, when using the drug, the development of anemia, leukopenia and thrombocytopenia is sometimes observed.
• Taking the drug may be accompanied by the appearance of itchy skin, rashes, urticaria and photosensitivity.
• Sometimes taking Movalis can be accompanied by the development of acute attacks of suffocation or bronchial asthma.
• From the side of the nervous system, dizziness, increased drowsiness or nervous excitability, tinnitus, emotional lability may occur.
• On the part of the cardiovascular system, changes in blood pressure, heart palpitations and edema sometimes develop.
• From the side of the visual system, it is possible to impair the clarity of vision or the development of conjunctivitis.

Expiration date
3 years.

Storage conditions
Store at a temperature not exceeding 25 ° C out of reach of children.